Louise Emmett

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1K citations

Urology, Oncology, Genitourinary Cancer +7

Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer

Wolfgang P. Fendler, Jérémie Calais, Matthias Eiber et al. · JAMA Oncology · 2019 · 749 citations · Full text

Prospective Comparison of ¹⁸ F-Fluoromethylcholine Versus ⁶⁸ Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy

Joshua James Morigi, Phillip D. Stricker, Pim J. van Leeuwen et al. · Journal of Nuclear Medicine · 2015 · 560 citations · Full text

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

Louise Emmett, James P Buteau, Nathan Papa et al. · European Urology · 2021 · 394 citations

Additive Diagnostic Value, Urology, Medical Imaging +8

The Impact of ⁶⁸Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study

Paul Roach, Roslyn J. Francis, Louise Emmett et al. · Journal of Nuclear Medicine · 2017 · 355 citations · Full text